Bradford Crutchfield - 21 Dec 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Commercial Officer
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol: TXG
Transactions as of: 21 Dec 2021
Net transactions value: +$257,172
Form type: 4
Filing time: 23 Dec 2021, 15:26:01 UTC
Previous filing: 15 Dec 2021
Next filing: 14 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Options Exercise	$5,626	+4,688	+11%	$1.20	47,743	21 Dec 2021	Direct
transaction	TXG	Class A Common Stock	Options Exercise	$251,546	+49,910	+105%	$5.04	97,653	21 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-4,688	-100%	$0.000000^*	0	21 Dec 2021	Class A Common Stock	4,688	$1.20	Direct	F1
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-49,910	-45%	$0.000000	61,757	21 Dec 2021	Class A Common Stock	49,910	$5.04	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option, originally for 25,000 shares, of which 25,000 shares have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2	This option, originally for 125,000 shares, of which 63,243 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.